Article
p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer.
The Journal of clinical endocrinology and metabolism - 1 Nov 2018
Loveday Chey, Josephs Katherine, Chubb Daniel, Gunning Adam, Izatt Louise, Tischkowitz Marc, Ellard Sian, Turnbull Clare
Abstract excerpt
Context: To date, penetrance figures for medullary thyroid cancer (MTC) for variants in rearranged during transfection (RET) have been estimated from families ascertained because of the presence of MTC. Objective: To gain estimates of penetrance, unbiased by ascertainment, we analyzed 61 RET mutations assigned as disease causing by the American Thyroid Association (ATA) in population whole-exome sequencing data....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
